These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 31653015)
1. The Synthetic Dipeptide Pidotimod Shows a Chemokine-Like Activity through CXC Chemokine Receptor 3 (CXCR3). Caccuri F; Bugatti A; Corbellini S; Roversi S; Zani A; Mazzuca P; Marsico S; Caruso A; Giagulli C Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653015 [TBL] [Abstract][Full Text] [Related]
2. The immunomodulatory molecule pidotimod induces the expression of the NOD-like receptor NLRP12 and attenuates TLR-induced inflammation. Fogli M; Caccuri F; Iaria ML; Giagulli C; Corbellini S; Campilongo F; Caruso A; Fiorentini S J Biol Regul Homeost Agents; 2014; 28(4):753-66. PubMed ID: 25620184 [TBL] [Abstract][Full Text] [Related]
3. CXCR3-mediated chemotaxis of human T cells is regulated by a Gi- and phospholipase C-dependent pathway and not via activation of MEK/p44/p42 MAPK nor Akt/PI-3 kinase. Smit MJ; Verdijk P; van der Raaij-Helmer EM; Navis M; Hensbergen PJ; Leurs R; Tensen CP Blood; 2003 Sep; 102(6):1959-65. PubMed ID: 12750173 [TBL] [Abstract][Full Text] [Related]
4. Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes. Korniejewska A; McKnight AJ; Johnson Z; Watson ML; Ward SG Immunology; 2011 Apr; 132(4):503-15. PubMed ID: 21255008 [TBL] [Abstract][Full Text] [Related]
5. IL-2/GM-CSF enhances CXCR3 expression in CAR-T cells via the PI3K/AKT and ERK1/2 pathways. Liu L; Cheng Y; Zhang F; Chen J; Tian P; Shi W; Zhou F; Yang M; Zhou M; Liu B J Cancer Res Clin Oncol; 2023 Aug; 149(9):5547-5557. PubMed ID: 36474002 [TBL] [Abstract][Full Text] [Related]
6. CXCL10/CXCR3 axis promotes the invasion of gastric cancer via PI3K/AKT pathway-dependent MMPs production. Zhou H; Wu J; Wang T; Zhang X; Liu D Biomed Pharmacother; 2016 Aug; 82():479-88. PubMed ID: 27470388 [TBL] [Abstract][Full Text] [Related]
7. Biased agonists of the chemokine receptor CXCR3 differentially control chemotaxis and inflammation. Smith JS; Nicholson LT; Suwanpradid J; Glenn RA; Knape NM; Alagesan P; Gundry JN; Wehrman TS; Atwater AR; Gunn MD; MacLeod AS; Rajagopal S Sci Signal; 2018 Nov; 11(555):. PubMed ID: 30401786 [TBL] [Abstract][Full Text] [Related]
9. Glycosaminoglycans Regulate CXCR3 Ligands at Distinct Levels: Protection against Processing by Dipeptidyl Peptidase IV/CD26 and Interference with Receptor Signaling. Metzemaekers M; Mortier A; Janssens R; Boff D; Vanbrabant L; Lamoen N; Van Damme J; Teixeira MM; De Meester I; Amaral FA; Proost P Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28703769 [TBL] [Abstract][Full Text] [Related]
10. PI3Kgamma (PI3Kgamma) is essential for efficient induction of CXCR3 on activated T cells. Barbi J; Cummings HE; Lu B; Oghumu S; Rückle T; Rommel C; Lafuse W; Whitacre CC; Satoskar AR Blood; 2008 Oct; 112(8):3048-51. PubMed ID: 18658026 [TBL] [Abstract][Full Text] [Related]
11. CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer. Zhang C; Li Z; Xu L; Che X; Wen T; Fan Y; Li C; Wang S; Cheng Y; Wang X; Qu X; Liu Y BMC Cancer; 2018 Apr; 18(1):462. PubMed ID: 29690901 [TBL] [Abstract][Full Text] [Related]
12. Resistin Enhances Monocyte Chemoattractant Protein-1 Production in Human Synovial Fibroblasts and Facilitates Monocyte Migration. Chen WC; Wang SW; Lin CY; Tsai CH; Fong YC; Lin TY; Weng SL; Huang HD; Liao KW; Tang CH Cell Physiol Biochem; 2019; 52(3):408-420. PubMed ID: 30845380 [TBL] [Abstract][Full Text] [Related]
13. HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation. Giagulli C; Magiera AK; Bugatti A; Caccuri F; Marsico S; Rusnati M; Vermi W; Fiorentini S; Caruso A Blood; 2012 Mar; 119(10):2274-83. PubMed ID: 22262769 [TBL] [Abstract][Full Text] [Related]
14. CXCR3-mediated T-cell chemotaxis involves ZAP-70 and is regulated by signalling through the T-cell receptor. Dar WA; Knechtle SJ Immunology; 2007 Apr; 120(4):467-85. PubMed ID: 17250586 [TBL] [Abstract][Full Text] [Related]
15. Functional Analysis of CXCR3 Splicing Variants and Their Ligands Using NanoBiT-Based Molecular Interaction Assays. Nguyen HT; Hurh S; Nguyen LP; Nguyen TU; Park HK; Seong JY; Lee CS; Ham BJ; Hwang JI Mol Cells; 2023 May; 46(5):281-297. PubMed ID: 36799104 [TBL] [Abstract][Full Text] [Related]
16. CXCL9 causes heterologous desensitization of CXCL12-mediated memory T lymphocyte activation. Giegold O; Ogrissek N; Richter C; Schröder M; Herrero San Juan M; Pfeilschifter JM; Radeke HH J Immunol; 2013 Apr; 190(7):3696-705. PubMed ID: 23447686 [TBL] [Abstract][Full Text] [Related]
17. CXCL11 promotes tumor progression by the biased use of the chemokine receptors CXCR3 and CXCR7. Puchert M; Obst J; Koch C; Zieger K; Engele J Cytokine; 2020 Jan; 125():154809. PubMed ID: 31437604 [TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory activity of pidotimod administered with standard antibiotic therapy in children hospitalized for community-acquired pneumonia. Esposito S; Garziano M; Rainone V; Trabattoni D; Biasin M; Senatore L; Marchisio P; Rossi M; Principi N; Clerici M J Transl Med; 2015 Sep; 13():288. PubMed ID: 26335787 [TBL] [Abstract][Full Text] [Related]